1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Finland Pharmaceuticals and Healthcare Report Q2 2016

Finland Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 66 pages

Includes 3 FREE quarterly updates

BMI View: Finland's healthcare system has suffered from a lack of cooperation between primaryhealthcare and specialised medical care in recent years. Although the Finnish healthcare system isundergoing reforms, it will be a while before such changes have an impact, especially considering the weakstate of the economy. In the long term, an aging population and high per capita spending will drive demandfor high-value medicines and quality medical services. However, we believe the associated rising costs willkeep the healthcare and pharmaceutical sectors a target for government cost-containment measures.

Headline Expenditure Projections

- Pharmaceuticals: EUR2.94bn (USD3.23bn) in 2015 to EUR3.03bn (USD3.24bn) in 2016;+3.1% inlocal currency terms and +0.3% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: EUR19.63bn (USD21.59bn) in 2015 to EUR20.42bn (USD21.85bn) in 2016; +4.0% in localcurrency terms and +1.2% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Finland Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Finland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Finland 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2014-2020) 26
Industry Risk/Reward Index 27
Western Europe Risk/Reward Index 27
Finland Risk/Reward Index 32
Rewards 32
Risks 32
Regulatory Review 34
Intellectual Property Issues 35
Pricing Regime 35
Reimbursement Regime 38
Market Overview 40
Healthcare Sector 41
Table: Healthcare Resources (Finland 2010-2015) 44
Table: Healthcare Personnel (Finland 2010-2015) 45
Table: Healthcare Activity (Finland 2010-2015) 45
Research And Development 45
Clinical Trials 46
Epidemiology 47
Competitive Landscape 51
Research-Based Industry 51
Table: Multinational Market Activity 52
Table: PIF Members 54
Pharmaceutical Distribution and Retail Sector 54
Demographic Forecast 55
Table: Population Headline Indicators (Finland 1990-2025) 56
Table: Key Population Ratios (Finland 1990-2025) 56
Table: Urban/Rural Population and Life Expectancy (Finland 1990-2025) 57
Table: Population By Age Group (Finland 1990-2025) 57
Table: Population By Age Group % (Finland 1990-2025) 58
Glossary 60
Methodology 62
Pharmaceutical Expenditure Forecast Model 62
Healthcare Expenditure Forecast Model 62
Notes On Methodology 63
Risk/Reward Index Methodology 64
Index Overview 65
Table: Pharmaceutical Risk/Reward Index Indicators 65
Indicator Weightings 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.